Drug-Drug Interaction Study Between Hydronidone and Entecavir, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide, and Tenofovir Amibufenamide

Clinical trial NCT07295873 · COMPLETED

Trial details

NCT number: NCT07295873
Sponsor: Beijing Continent Pharmaceutical Co, Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis B Liver Fibrosis DDI (Drug-Drug Interaction)

Start date: 2026-03-15
Primary completion: 2026-05-29
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.